Evaluation of Metabolic Markers for the Prediction of DDI of Various CYP3A Substrates and Inhibitors
Clinical trial NCT02975037 · COMPLETED
Trial details
- NCT number
- NCT02975037
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2017-03-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.